Download PDF
Thromb Haemost 1997; 77(06): 1221-1222
DOI: 10.1055/s-0038-1656145
Letters to the Editor
Schattauer GmbH Stuttgart

Soluble P-selectin, Thrombocytopenia and von Willebrand Factor in HIV Infected Patients

Andrew D Blann
Thrombosis, Haemostasis and Vascular Biology Unit, The University Department of Medicine, The City Hospital, Birmingham, UK
,
Martine Seigneur
1   Departments of Haematology and Medicine, University Hospital of Bordeaux II, Bordeaux, France
,
Joel Constans
1   Departments of Haematology and Medicine, University Hospital of Bordeaux II, Bordeaux, France
,
Jean Luc Pellegrin
1   Departments of Haematology and Medicine, University Hospital of Bordeaux II, Bordeaux, France
,
Claude Conri
1   Departments of Haematology and Medicine, University Hospital of Bordeaux II, Bordeaux, France
› Author Affiliations
Further Information

Publication History

Received 31 December 1996

Accepted after revision 19 February 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Tabib A, Greeland T, Mercier I, Loire R, Mornex JF. Coronary lesions in young HIV-positive patients at necropsy. Lancet 1992; 340: 730
    PubMedGoogle Scholar
  • 2 Capron L, Kim YU, Laurin C, Bruneval P, Fiessinger DIN. Atheroembolism in HIV-positive individuals. Lancet 1992; 340: 1039-1040
    PubMedGoogle Scholar
  • 3 Constans J, Marchand JM, Conri C, Peuchant E, Seigneur M, Rispal P, Lasseur C, Pellegrin JL, Leng B. Asymptomatic atherosclerosis in HIV-positive patients: a case-controlled ultrasound study. Ann Med 1995; 27: 683-685
    CrossrefPubMedGoogle Scholar
  • 4 Cotte JR, Lackner R, Xenig P, Pillary G. Deep vein thrombosis in patients with AIDS. NY State J Med 1990; 20: 159-161
    PubMedGoogle Scholar
  • 5 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
    CrossrefPubMedGoogle Scholar
  • 6 Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA. Endothelial cell dysfunction in HIV infection. J AIDS 1992; 5: 127-131
    PubMedGoogle Scholar
  • 7 Cenacchi G, Re MC, Pasquinelli G, Furlini G, Apkarian RP, La PlaceM, Martinelli GN. Human immunodeficiency virus type-1 (HIV-1) infection of endothelial cells in vitro: a virological, ultrastructural and immuno- cytochemical approach. J Submicrosc Cytol Pathol 1992; 24 (02) 155-161
    PubMedGoogle Scholar
  • 8 Teitel J, Shore A, Read SE, Shiavone A. Immune function of vascular endothelial cells is impaired by HIV. J Infect Dis 1989; 160 (03) 551-552
    CrossrefPubMedGoogle Scholar
  • 9 Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, Sarlat C. von Willebrand factor antigen, tissue type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1 related clinical disease: Independent prognostic relevance of tissue type plasminogen activator. J Lab Clin Med 1992; 120: 411-419
    PubMedGoogle Scholar
  • 10 Blann AD, McCollum CN. von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vase Surg 1994; 08: 10-15
    CrossrefPubMedGoogle Scholar
  • 11 Louache F, Bettaieb A, Henri A, Oskenhendler E, Farcet JP, Bierling P, Seligmann M, Vainchenker W. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenia purpura. Blood 1991; 78: 2697-2705
    PubMedGoogle Scholar
  • 12 Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation?. Atherosclerosis 1997; 125: 135-138
    PubMedGoogle Scholar
  • 13 Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci 1993; 50: 221-234
    PubMedGoogle Scholar
  • 14 Seigneur M, Constans J, Blann A, Renard M, Pellegrin JL, Amiral J, Boisseau M, Conri C. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost 1997; 77: 646-649
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Guerin V, Morlat P, Chene G, Grobost F, Aubertin J, Boisseau M. High levels of plasmatic von Willebrand factor limits the bleeding time in thrombocytopenic HIV-infected patients. Thromb Haemost 1995; 74: 803-804
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Dominguez A, Gamallo G, Garcia R, Lopez-Pastor A, Pena JM, Vazquez J. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol 1994; 47: 999-1003
    CrossrefPubMedGoogle Scholar
  • 17 Bettaieb A, Fromot P, Louache F, Oksenhendler E, Vainchenker W, Duedari N, Bierling P. Presence of cross-reactive antibody between HIV and platelet glycoprotein in HIV-related immune thrombocytopenic purpura. Blood 1992; 80: 262-269
    PubMedGoogle Scholar